John Hancock US High Dividend ETF
JHDV
3 hedge funds and large institutions have $15.2M invested in John Hancock US High Dividend ETF in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
112% more capital invested
Capital invested by funds: $7.15M → $15.2M (+$8M)
86.36% more ownership
Funds ownership: 86.81% → 173.16% (+86%)
50% more funds holding
Funds holding: 2 → 3 (+1)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$7.34M |
| 2 |
Morgan Stanley
New York
|
+$39 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$618 |
JHDV Hedge Fund Activity: Q3 2025 in Review
3 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in John Hancock US High Dividend ETF (JHDV) for Q3 2025, worth a combined $15.2M — up 112% from $7.15M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new JHDV positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Manulife (Manufacturers Life Insurance), adding an estimated $7.34M. The largest seller was Royal Bank of Canada, cutting an estimated $618.
- 3 institutional investors held John Hancock US High Dividend ETF (JHDV) as of Q3 2025, up from 2 in Q2 2025.
- Funds reported $15.2M of John Hancock US High Dividend ETF stock for Q3 2025, up 112% quarter-over-quarter.
- 1 fund opened new John Hancock US High Dividend ETF positions in Q3 2025 and 0 closed out, a net change of +1 holder.
- The largest John Hancock US High Dividend ETF buyer in Q3 2025 was Manulife (Manufacturers Life Insurance), an estimated $7.34M added.
- The largest John Hancock US High Dividend ETF seller in Q3 2025 was Royal Bank of Canada, an estimated $618 sold.
Based on aggregated 13F filings for Q3 2025.